Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Open-Label Study of the Efficacy and Safety of Immune Globulin Intravenous (Human), 10% TVR Solution in Adult Subjects With Chronic Idiopathic Thrombocytopenic Purpura

NCT00162006 is registered in ClinicalTrials.gov with Baxalta now part of Shire as lead sponsor.

NCT NCT00162006
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00162006 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Open-Label Study of the Efficacy and Safety of Immune Globulin Intravenous (Human), 10% TVR Solution in Adult Subjects With Chronic Idiopathic Thrombocytopenic Purpura
Lead sponsor
Baxalta now part of Shire
Phase
Phase 2
Overall status
Completed
Start date
January 13, 2003
Completion date
December 3, 2003
Enrollment
28 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

immune thrombocytopenic purpura (itp)